Report a side effect Contact Us
  • Who We Are
    Who We Are
    EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
    • Overview
    • Vision, Mission & Values
    • Our History
    • Chairman Message
    • News and Media
      • Press Releases
      • Media Library
    • Sustainability & CSR
  • Manufacturing Facilities
    Manufacturing Facilities
    EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.


    • Overview
    • Factory 1
    • Factory 2
    • Factory 3
    • Eiaco Factory
    • Eipico Plastic Factory
    • Industry Expansion
  • Science & Medicine
    Science & Medicine
    EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
    • Products
    • Products (Alphabetical)
    • R&D and Quality
    • Global Accreditation
    • Regulatory Affairs
  • Global
    Global
    EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
    • Overview
    • Our Export History
    • Eipico Destination
  • Investor Relations
    Investor Relations
    • Investor Relations
    • Annual Reports
  • EIPICO 3
    EIPICO 3
    The First Modular Biological and Biosimilar Facility in Egypt
    • EIPICO 3 (Biologicals & Biosimilars)
Supreme Council of University Hospitals and EIPICO Pharmaceuticals Sign Cooperation Agreement  

9 March 2025

 
 In line with the Supreme Council of University Hospitals' role in organizing and improving the quality of healthcare in university hospitals to achieve distinguished health services that satisfy and are felt by the citizen,

 And continuing the Council's support for all avenues of cooperation with national institutions, the private sector, and civil society organizations in all areas that contribute to the development of the university hospital system for the Egyptian citizen.

 And affirming the social responsibility of EIPICO Pharmaceuticals towards serving the community, which is reflected in one of its aspects: contributing to supporting training programs for healthcare providers and public awareness.
 A cooperation agreement was signed between the Supreme Council of University Hospitals and EIPICO Pharmaceuticals.
 The agreement was signed by Professor Dr. Omar Sherif Omar, Secretary-General of the Supreme Council of University Hospitals, and Dr. Ahmed Kelani, Chairman of the Board and Managing Director of the Egyptian International Pharmaceutical Industries Company (EIPICO).

 Professor Dr. Omar Sherif Omar stated that the agreement aims to support the national institutional identity of university hospitals through the annual publications of the Supreme Council of University Hospitals' guide and the university hospitals' directory, and to enhance programs for developing the capabilities of healthcare providers, including doctors, pharmacists, and nurses in university hospitals.

 Dr. Ahmed Kelani stated that signing this agreement reinforces EIPICO Pharmaceutical's national standing as a leading company locally and regionally in various therapeutic areas, and also confirms its social responsibility by entering into a partnership with the Supreme Council of University Hospitals to support various training programs to achieve the best results for patients, ultimately leading to a sustainable partnership.





WE ARE EIPICO

EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million, currently raised to EGP 1500 Million.

Quick Links

  • EIPICO 3
  • News
  • Products
  • Global accreditation
  • Global
  • Investor relations

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

eipico@eipico.com.eg

Back to top
Powered by EIPICO Team
     Visitors Count : 1547679